| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 187.54 mm | 187.54 mm | 187.54 mm | 187.54 mm | 187.54 mm | 187.54 mm |
| Cash burn (monthly) | 29.35 mm | 4.06 mm | 17.04 mm | 11.66 mm | (no burn) | 4.48 mm |
| Cash used (since last report) | 82.14 mm | 11.37 mm | 47.70 mm | 32.62 mm | n/a | 12.53 mm |
| Cash remaining | 105.40 mm | 176.17 mm | 139.84 mm | 154.92 mm | n/a | 175.01 mm |
| Runway (months of cash) | 3.6 | 43.3 | 8.2 | 13.3 | n/a | 39.1 |
| 13F holders | Current |
|---|---|
| Total holders | 93 |
| Opened positions | 41 |
| Closed positions | 74 |
| Increased positions | 28 |
| Reduced positions | 13 |
| 13F shares | Current |
|---|---|
| Total value | 815.11 bn |
| Total shares | 47.79 mm |
| Total puts | 166.50 k |
| Total calls | 55.60 k |
| Total put/call ratio | 3.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Ra Capital Management | 5.10 mm | $107.01 bn |
| VR Adviser | 4.40 mm | $92.36 bn |
| Venrock Healthcare Capital Partners III | 4.40 mm | $0.00 |
| Deep Track Capital | 4.06 mm | $85.25 bn |
| Biotechnology Value Fund L P | 4.01 mm | $22.76 mm |
| BVF | 3.92 mm | $82.33 bn |
| JHG Janus Henderson | 3.20 mm | $67.11 bn |
| Viking Global Investors | 2.93 mm | $61.60 bn |
| STT State Street | 2.08 mm | $43.64 bn |
| Polar Capital | 1.74 mm | $36.62 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Dec 24 | Ra Capital Management | Common Stock | Other | Dispose J | Yes | No | 0 | 535,000 | 0.00 | 4,563,211 |
| 9 Dec 24 | Ra Capital Management | Pre-Funded Warrants Common Stock | Other | Acquire J | Yes | No | 0.0001 | 535,000 | 53.50 | 3,610,000 |
| 8 Nov 24 | Partners L P/il BVF | Common Stock, $0.0001 par value | Other | Dispose J | No | No | 0 | 240,000 | 0.00 | 87,911 |
| 8 Nov 24 | Partners L P/il BVF | Common Stock, $0.0001 par value | Other | Dispose J | No | No | 0 | 2,378,000 | 0.00 | 662,970 |
| 8 Nov 24 | Partners L P/il BVF | Common Stock, $0.0001 par value | Other | Dispose J | No | No | 0 | 3,062,000 | 0.00 | 830,237 |
| 8 Nov 24 | Partners L P/il BVF | Pre-Funded Warrant Common Stock, $0.0001 par value | Other | Acquire J | No | No | 0.0001 | 240,000 | 24.00 | 240,000 |
| 8 Nov 24 | Partners L P/il BVF | Pre-Funded Warrant Common Stock, $0.0001 par value | Other | Acquire J | No | No | 0.0001 | 2,378,000 | 237.80 | 2,378,000 |
| 8 Nov 24 | Partners L P/il BVF | Pre-Funded Warrant Common Stock, $0.0001 par value | Other | Acquire J | No | No | 0.0001 | 3,062,000 | 306.20 | 3,062,000 |
| 16 Sep 24 | Scott Bizily | Common Stock | Sell | Dispose S | No | Yes | 16.33 | 500 | 8.16 k | 6,781 |
| 16 Sep 24 | Scott Bizily | Common Stock | Option exercise | Acquire M | No | Yes | 6.49 | 500 | 3.25 k | 7,281 |
